Last updated 2026-07-20
Portfolio
1
in our dataset
Rounds participated
1
Rounds led
0
Rounds' value
$11.1M
total disclosed, rounds participated
Stages
—
About
Armistice Capital is a global, long/short, value-oriented, and event-driven hedge fund that primarily invests in the healthcare and consumer sectors. The firm employs a strategy that combines value investing with event-driven analysis, aiming for compelling risk-adjusted returns while maintaining significant hedges to mitigate risks.
Portfolio · 1
Investment activity
Portfolio by sector
Health Tech & Life Sciences2
Q&A
- What is Armistice Capital's primary investment focus by sector?
- Armistice Capital primarily focuses on the Health Tech & Life Sciences sector, with all of its known portfolio companies operating in this area.
- What type of funding rounds does Armistice Capital typically participate in?
- Armistice Capital has participated in PIPE (Private Investment in Public Equity) rounds.
- Can you name some of Armistice Capital's portfolio companies?
- Armistice Capital's portfolio includes Purple Biotech, which develops tumor-immune evasion and drug resistance therapies.
- When did Armistice Capital make its most recent known investment?
- Armistice Capital made a new portfolio investment in September 2024.
- What is the typical investment range for Armistice Capital?
- Armistice Capital's investment range is between $1.24M and $11.1M.
- When was Armistice Capital founded?
- Armistice Capital was created in May 2019, according to startupim data.
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
Identifiers & details
| Legal name | Armistice Capital, LLC |
|---|---|
| Founded | 2012 |
Radar intelligence
Patents
| EPO | 1 |
|---|